➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Baxter
Boehringer Ingelheim
McKesson
Express Scripts

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Details for Patent: 9,577,864

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,577,864
Title:Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
Abstract: In a software receiver, a received electromagnetic signal is sampled in "slices", each having a duration of some multiple of a reference frequency. The samples of each slice are correlated with values in a pair of reference signals, such as sine and cosine, at the reference frequency. This yields a two-tuple for each slice, which two-tuples may be stored. The stored two-tuples can be simply added to arrive at a correlation value of narrower bandwidth than that of any slice taken alone. The stored two-tuples can be taken in sequence, each rotated by some predetermined angle relative to its predecessor in sequence, and the rotated two-tuples summed to arrive at a correlation value with respect to a frequency that is offset from the reference frequency to an extent that relates to the predetermined angle. In this way, the receiver is able to proceed despite the transmitted frequency not being known exactly in advance and does not require prodigious storage or computational resources.
Inventor(s): Fleming; Robert Alan (Nicasio, CA), Kushner; Cherie Elaine (Nicasio, CA), McAllister; William (Saratoga, CA), Zdeblick; Mark (Portola Valley, CA)
Assignee: Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:14/917,834
Patent Claim Types:
see list of patent claims
Use; Formulation; Device;

Recent additions to Drugs Protected by US Patent 9,577,864

These patents are from the daily update and have not yet been integrated into the regular database
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Product Substance Delist Req. Patent Expiration Usecode Patented / Exclusive Use
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Type >RLD >Patent No. >Product >Substance >Delist Req. >Patent Expiration >Usecode >Patented / Exclusive Use

Drugs Protected by US Patent 9,577,864

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,577,864

PCT Information
PCT FiledOctober 03, 2013PCT Application Number:PCT/IB2013/059084
PCT Publication Date:April 02, 2015PCT Publication Number: WO2015/044722

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKesson
Colorcon
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.